Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001712365 | SCV000517854 | likely benign | not provided | 2021-02-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001188685 | SCV001355811 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-11-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002062290 | SCV002459200 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-03-16 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996034 | SCV004814652 | likely benign | Marfan syndrome | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001188685 | SCV006002699 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2025-01-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |